Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 IMVT Q1 2026 Earnings EPS Misses Estimates as Clinical Investment Intensifies AMAL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter GBDC Q1 2026 Earnings Significant EPS Miss Amid Challenging Credit Environment CMMB Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Biotech Continues Without Revenue RMBI Q1 2026 Earnings Solid EPS Amidst Flat Market Reaction